text:
The wind and rain that blew through on Christmas Day spawned damaging tornadoes in other parts of the South, but Terrebonne and Lafourche escaped relatively unscathed.
The wind and rain that blew through on Christmas Day spawned damaging tornadoes in other parts of the South, but Terrebonne and Lafourche escaped relatively unscathed.
Power was knocked out in multiple homes, primarily because of the wind, utility officials said.
Wind gusts of up to 35 mph were recorded Christmas Day at the Houma-Terrebonne Airport, National Weather Service forecasters said.
In Gibson, where about 1,000 customers were without power for up to 90 minutes, the outage is blamed on both wind and fire.
Gibson resident Donna McKinley points to a line of singed and leaning utility poles in a field, which she said were scorched by a fire set to burn sugar cane. The field is in the 4700 block of La. 182.
She alleges the fire weakened the still-leaning poles, which bowed in the brisk wind and knocked out power to her home and others.
"Back-to-back power outages disrupted (Christmas Day) gatherings and may have damaged some of the new electronic gifts and computers that were in use that day," McKinley said. "The sugar-cane farmer should be held accountable."
A man who identified himself as the landowner but declined to provide his name denied that a fire was to blame, pointing instead to the wind.
That area of Gibson gets power from the South Louisiana Electric Cooperative Association.
"The wind had a lot to do with pushing it over," SLECA General Manager Joe Ticheli said of the poles.
Throughout SLECA's service area, which includes Terrebonne, Assumption, Lafourche, St. Martin and St. Mary parishes, "there were a couple thousand out at any one given time" because of the wind, Ticheli said.
About 250 local Entergy customers lost power Christmas Day — 100 in Lafourche and 150 in Terrebonne, Entergy spokeswoman Molly Jahncke said.
"People were so understanding. ... They knew the weather was so bad, and the wind was bad," Ticheli said. "We had all our guys that could go out, go out."
The poles were still leaning on Wednesday afternoon. The power has been in the attached lines and rerouted until the poles can be replaced, Ticheli said.
Terrebonne and Lafourche can expect cloudy and cool skies today and tomorrow morning, with daytime temperatures forecast to reach about 50, according to WWL-TV meteorologists.
The next chance for rain comes Friday afternoon ahead of another approaching cold front, forecasters said. The rain chance for Friday afternoon and evening is 60 percent.
Friday's rain is not expected to be severe.
Staff Writer Katie Urbaszewski can be reached at 448-7617 or firstname.lastname@example.com.


text:
Live Music
Luke Langford & the 331 South Band @ Havana Beach Rooftop Bar
Bummer dude!
This event has already happened. To be sure you don't miss anymore events in South Walton, visit the SoWal Events Calendar.
It's Sunday Funday at Havana Beach Rooftop Bar with live music by Luke Langford and the 331 South Band from 5-9pm.
Come out and close your weekend with your favorite beverage, good tunes and a beautiful sunset view overlooking the Gulf of Mexico in Rosemary Beach, Florida.
Havana Beach Rooftop Bar celebrations will continue throughout Summer 2016.
Daily Happy Hour offerings between 3-6 pm
Live Music on Wed & Thu nights starting at 6 pm featuring Panhandle-based musicians
Cocktails & Classics with classic movie selections playing every Saturday through Nov.
Sunday Funday with board games, live Texas country tunes from Luke Langford and the 331 South Band, cocktail specials, and activities.
We will see you on the Rooftop this season! Check SoWal.com Music Calendar for live music coming to the rooftop here!
Step up to the Emerald Coast skyline at Havana Beach Rooftop Lounge where we relax and dream under the sun, moon and stars. Havana Beach Rooftop Lounge is located at the AAA Four Diamond and Forbes four-star Pearl Hotel in Rosemary Beach, Florida. The rooftop lounge is open daily from 11 am to 9 pm (weather permitting) with a full bar, including an extensive wine list and a mixed cocktail menu for ages 21 and over. Dining includes fresh gulf ceviche and small plates.
More Live Music at The Pearl Hotel, Havana Beach Bar & Grill
|5:30 pm
|Mari Gleason @ Havana Beach Rooftop Bar
|The Pearl Hotel, Havana Beach Bar & Grill
|10:00 am
|Jamah Terry @ Havana Beach Bar & Grill
|The Pearl Hotel, Havana Beach Bar & Grill
|10:00 am
|Jamah Terry @ Havana Beach Bar & Grill
|The Pearl Hotel, Havana Beach Bar & Grill
Map of this Event
At a Glance
Link to Business
More live music?

subset: commoncrawl


text:
(from Ch. 111, par. 8301-1)
(Section scheduled to be repealed on January 1, 2023)
Sec. 1.
Short title.
This Act may be cited as the
Wholesale Drug Distribution Licensing Act.
(Source: P.A. 87-594
Sec. 3.
References to Department or Director of Professional Regulation.
References in this Act (i) to the Department of Professional Regulation are
deemed, in appropriate contexts, to be references to the Department of Financial and Professional Regulation
and (ii) to the Director of Professional Regulation are
deemed, in appropriate contexts, to be references to the Secretary of Financial and Professional Regulation.
(Source: P.A. 95-689, eff. 10-29-07
(from Ch. 111, par. 8301-5)
Sec. 5.
This Act applies to any person, partnership,
corporation, or business firm engaging in the wholesale distribution of
human prescription drugs within this State.
(from Ch. 111, par. 8301-10)
Sec. 10.
The purpose of this Act is to implement the
Federal Prescription Drug Marketing Act of 1987 (PDMA), U.S. Pub. L.
100-293, 102 Stat. 95, codified at U.S.C. Sec. 321 et seq.; and
particularly PDMA requirements that no person or entity may engage in the
wholesale distribution of human prescription drugs in any state unless the
person or entity is licensed by that state in accordance with federally
prescribed minimum standards, terms, and conditions as set forth in
guidelines issued by United States Food and Drug Administration (FDA)
(from Ch. 111, par. 8301-15)
Sec. 15.
As used in this Act:
"Authentication" means the affirmative verification, before any wholesale distribution of a prescription drug occurs, that each transaction listed on the pedigree has occurred.
"Authorized distributor of record" means a wholesale distributor with whom a manufacturer has established an ongoing relationship to distribute the manufacturer's prescription drug. An ongoing relationship is deemed to exist between a wholesale distributor and a manufacturer when the wholesale distributor, including any affiliated group of the wholesale distributor, as defined in Section 1504 of the Internal Revenue Code, complies with the following:
(1) The wholesale distributor has a written agreement
currently in effect with the manufacturer evidencing the ongoing relationship; and
(2) The wholesale distributor is listed on the
manufacturer's current list of authorized distributors of record, which is updated by the manufacturer on no less than a monthly basis.
"Blood" means whole blood collected from a single donor and processed
either for transfusion or further manufacturing.
"Blood component" means that part of blood separated by physical or
mechanical means.
"Board" means the State Board of Pharmacy of the Department of
Professional Regulation.
"Chain pharmacy warehouse" means a physical location for prescription drugs that acts as a central warehouse and performs intracompany sales or transfers of the drugs to a group of chain or mail order pharmacies that have the same common ownership and control. Notwithstanding any other provision of this Act, a chain pharmacy warehouse shall be considered part of the normal distribution channel.
"Co-licensed partner or product" means an instance where one or more parties have the right to engage in the manufacturing or marketing of a prescription drug, consistent with the FDA's implementation of the Prescription Drug Marketing Act.
"Department" means the Department of Financial and
Professional Regulation.
"Drop shipment" means the sale of a prescription drug to a wholesale distributor by the manufacturer of the prescription drug or that manufacturer's co-licensed product partner, that manufacturer's third party logistics provider, or that manufacturer's exclusive distributor or by an authorized distributor of record that purchased the product directly from the manufacturer or one of these entities whereby the wholesale distributor or chain pharmacy warehouse takes title but not physical possession of such prescription drug and the wholesale distributor invoices the pharmacy, chain pharmacy warehouse, or other person authorized by law to dispense or administer such drug to a patient and the pharmacy, chain pharmacy warehouse, or other authorized person receives delivery of the prescription drug directly from the manufacturer, that manufacturer's third party logistics provider, or that manufacturer's exclusive distributor or from an authorized distributor of record that purchased the product directly from the manufacturer or one of these entities.
"Drug sample" means a unit of a prescription drug that is not intended to
be sold and is intended to promote the sale of the drug.
"Facility" means a facility of a wholesale distributor where prescription drugs are stored, handled, repackaged, or offered for sale.
"FDA" means the United States Food and Drug Administration.
"Manufacturer" means a person licensed or approved by the FDA to engage in the manufacture of drugs or devices, consistent with the definition of "manufacturer" set forth in the FDA's regulations and guidances implementing the Prescription Drug Marketing Act.
"Manufacturer's exclusive distributor" means anyone who contracts with a manufacturer to provide or coordinate warehousing, distribution, or other services on behalf of a manufacturer and who takes title to that manufacturer's prescription drug, but who does not have general responsibility to direct the sale or disposition of the manufacturer's prescription drug. A manufacturer's exclusive distributor must be licensed as a wholesale distributor under this Act and, in order to be considered part of the normal distribution channel, must also be an authorized distributor of record.
"Normal distribution channel" means a chain of custody for a prescription drug that goes, directly or by drop shipment, from (i) a manufacturer of the prescription drug, (ii) that manufacturer to that manufacturer's co-licensed partner, (iii) that manufacturer to that manufacturer's third party logistics provider, or (iv) that manufacturer to that manufacturer's exclusive distributor to:
(1) a pharmacy or to other designated persons
authorized by law to dispense or administer the drug to a patient;
(2) a wholesale distributor to a pharmacy or other
designated persons authorized by law to dispense or administer the drug to a patient;
(3) a wholesale distributor to a chain pharmacy
warehouse to that chain pharmacy warehouse's intracompany pharmacy to a patient or other designated persons authorized by law to dispense or administer the drug to a patient;
(4) a chain pharmacy warehouse to the chain pharmacy
warehouse's intracompany pharmacy or other designated persons authorized by law to dispense or administer the drug to the patient;
(5) an authorized distributor of record to one other
authorized distributor of record to an office-based health care practitioner authorized by law to dispense or administer the drug to the patient; or
(6) an authorized distributor to a pharmacy or other
persons licensed to dispense or administer the drug.
"Pedigree" means a document or electronic file containing information that records each wholesale distribution of any given prescription drug from the point of origin to the final wholesale distribution point of any given prescription drug.
"Person" means and includes a natural person, partnership, association,
corporation, or any other legal business entity.
"Pharmacy distributor" means any pharmacy licensed in this State or
hospital pharmacy that is engaged in the delivery or distribution of
prescription drugs either to any other pharmacy licensed in this State or
to any other person or entity including, but not limited to, a wholesale
drug distributor engaged in the delivery or distribution of prescription
drugs who is involved in the actual, constructive, or attempted transfer of
a drug in this State to other than the ultimate consumer except as
otherwise provided for by law.
"Prescription drug" means any human drug, including any biological product (except for blood and blood components intended for transfusion or biological products that are also medical devices), required by federal law or
regulation to be dispensed only by a prescription, including finished
dosage forms and bulk drug substances
subject to Section
503 of the Federal Food, Drug and Cosmetic Act.
"Repackage" means repackaging or otherwise changing the container, wrapper, or labeling to further the distribution of a prescription drug, excluding that completed by the pharmacist responsible for dispensing the product to a patient.
"Secretary" means the Secretary of Financial and Professional Regulation.
"Third party logistics provider" means anyone who contracts with a prescription drug manufacturer to provide or coordinate warehousing, distribution, or other services on behalf of a manufacturer, but does not take title to the prescription drug or have general responsibility to direct the prescription drug's sale or disposition. A third party logistics provider must be licensed as a wholesale distributor under this Act and, in order to be considered part of the normal distribution channel, must also be an authorized distributor of record.
"Wholesale distribution"
means the distribution
of prescription drugs to persons other than a consumer or patient, but does
not include any of the following:
(1) Intracompany sales of prescription drugs,
meaning (i) any transaction or transfer between any division, subsidiary, parent, or affiliated or related company under the common ownership and control of a corporate entity or (ii) any transaction or transfer between co-licensees of a co-licensed product.
(2) The sale, purchase, distribution, trade, or
transfer of a prescription drug or offer to sell, purchase, distribute, trade, or transfer a prescription drug for emergency medical reasons.
(3) The distribution of prescription drug samples by
manufacturers' representatives.
(4) Drug returns, when conducted by a hospital,
health care entity, or charitable institution in accordance with federal regulation.
(5) The sale of minimal quantities of prescription
drugs by licensed pharmacies to licensed practitioners for office use or other licensed pharmacies.
(6) The sale, purchase, or trade of a drug, an offer
to sell, purchase, or trade a drug, or the dispensing of a drug pursuant to a prescription.
(7) The sale, transfer, merger, or consolidation of
all or part of the business of a pharmacy or pharmacies from or with another pharmacy or pharmacies, whether accomplished as a purchase and sale of stock or business assets.
(8) The sale, purchase, distribution, trade, or
transfer of a prescription drug from one authorized distributor of record to one additional authorized distributor of record when the manufacturer has stated in writing to the receiving authorized distributor of record that the manufacturer is unable to supply the prescription drug and the supplying authorized distributor of record states in writing that the prescription drug being supplied had until that time been exclusively in the normal distribution channel.
(9) The delivery of or the offer to deliver a
prescription drug by a common carrier solely in the common carrier's usual course of business of transporting prescription drugs when the common carrier does not store, warehouse, or take legal ownership of the prescription drug.
(10) The sale or transfer from a retail pharmacy,
mail order pharmacy, or chain pharmacy warehouse of expired, damaged, returned, or recalled prescription drugs to the original manufacturer, the originating wholesale distributor, or a third party returns processor.
"Wholesale drug distributor" means anyone
engaged in the
wholesale distribution of prescription drugs into, out of, or within the State, including without limitation
manufacturers; repackers; own label distributors; jobbers; private
label distributors; brokers; warehouses, including manufacturers' and
distributors' warehouses; manufacturer's exclusive distributors; and authorized distributors of record; drug wholesalers or distributors; independent wholesale drug traders; specialty wholesale distributors; third party logistics providers; and retail pharmacies that conduct wholesale distribution; and chain pharmacy warehouses that conduct wholesale distribution. In order to be considered part of the normal distribution channel, a wholesale distributor must also be an authorized distributor of record.
(Source: P.A. 97-804, eff. 1-1-13.)
(from Ch. 111, par. 8301-20)
Sec. 20.
Prohibited drug purchases or receipt.
It shall be unlawful
for any person or entity located in this State to knowingly receive any prescription
drug from any source other than a person or entity required by the laws of this State to be licensed to ship into, out of, or within this State. A person or entity licensed under the laws of this State shall
include, but is not limited to, a wholesale distributor, manufacturer,
pharmacy distributor, or pharmacy. Any person violating
this Section shall, upon conviction, be adjudged guilty of a Class C
misdemeanor. A second violation shall constitute a Class 4 felony.
Sec. 24.
(Source: P.A. 95-689, eff. 10-29-07. Repealed by P.A. 98-692, eff. 7-1-14.)
(from Ch. 111, par. 8301-25)
Sec. 25.
Wholesale drug distributor licensing requirements.
(a) Every resident wholesale distributor who engages in the wholesale distribution of prescription drugs must be licensed by the Department, and every non-resident wholesale distributor must be licensed in this State if it ships prescription drugs into this State, in accordance with this Act, before engaging in wholesale distributions of wholesale prescription drugs.
(b) The Department shall require without limitation all of the following information from each applicant for licensure under this Act:
(1) The name, full business address, and telephone
number of the licensee.
(2) All trade or business names used by the licensee.
(3) Addresses, telephone numbers, and the names of
contact persons for all facilities used by the licensee for the storage, handling, and distribution of prescription drugs.
(4) The type of ownership or operation, such as a
partnership, corporation, or sole proprietorship.
(5) The name of the owner or operator of the
wholesale distributor, including:
(A) if a natural person, the name of the natural
(B) if a partnership, the name of each partner
and the name of the partnership;
(C) if a corporation, the name and title of each
corporate officer and director, the corporate names, and the name of the state of incorporation; and
(D) if a sole proprietorship, the full name of
the sole proprietor and the name of the business entity.
(6) A list of all licenses and permits issued to the
applicant by any other state that authorizes the applicant to purchase or possess prescription drugs.
(7) The name of the designated representative for the
wholesale distributor, together with the personal information statement and fingerprints, as required under subsection (c) of this Section.
(8) Minimum liability insurance and other insurance
as defined by rule.
(9) Any additional information required by the
(c) Each wholesale distributor must designate an individual representative who shall serve as the contact person for the Department. This representative must provide the
Department with all of the following information:
(1) Information concerning whether the person has
been enjoined, either temporarily or permanently, by a court of competent jurisdiction from violating any federal or State law regulating the possession, control, or distribution of prescription drugs or criminal violations, together with details concerning any such event.
(2) A description of any involvement by the person
with any business, including any investments, other than the ownership of stock in a publicly traded company or mutual fund which manufactured, administered, prescribed, distributed, or stored pharmaceutical products and any lawsuits in which such businesses were named as a party.
(3) A description of any misdemeanor or felony
criminal offense of which the person, as an adult, was found guilty, regardless of whether adjudication of guilt was withheld or whether the person pled guilty or nolo contendere. If the person indicates that a criminal conviction is under appeal and submits a copy of the notice of appeal of that criminal offense, the applicant must, within 15 days after the disposition of the appeal, submit to the Department a copy of the final written order of disposition.
(4) The designated representative of an applicant for
licensure as a wholesale drug distributor shall have his or her fingerprints submitted to the Department of State Police in an electronic format that complies with the form and manner for requesting and furnishing criminal history record information as prescribed by the Department of State Police. These fingerprints shall be checked against the Department of State Police and Federal Bureau of Investigation criminal history record databases now and hereafter filed. The Department of State Police shall charge applicants a fee for conducting the criminal history records check, which shall be deposited into the State Police Services Fund and shall not exceed the actual cost of the records check. The Department of State Police shall furnish, pursuant to positive identification, records of Illinois convictions to the Department. The Department may require applicants to pay a separate fingerprinting fee, either to the Department or to a vendor. The Department, in its discretion, may allow an applicant who does not have reasonable access to a designated vendor to provide his or her fingerprints in an alternative manner. The Department may adopt any rules necessary to implement this Section.
The designated representative of a licensee shall
receive and complete continuing training in applicable federal and State laws governing the wholesale distribution of prescription drugs.
(d) The Department may not issue a wholesale distributor license to an applicant, unless the Department first:
(1) ensures that a physical inspection of the
facility satisfactory to the Department has occurred at the address provided by the applicant, as required under item (1) of subsection (b) of this Section; and
(2) determines that the designated representative
meets each of the following qualifications:
(A) He or she is at least 21 years of age.
(B) He or she has been employed full-time for at
least 3 years in a pharmacy or with a wholesale distributor in a capacity related to the dispensing and distribution of, and recordkeeping relating to, prescription drugs.
(C) He or she is employed by the applicant full
time in a managerial level position.
(D) He or she is actively involved in and aware
of the actual daily operation of the wholesale distributor.
(E) He or she is physically present at the
facility of the applicant during regular business hours, except when the absence of the designated representative is authorized, including without limitation sick leave and vacation leave.
(F) He or she is serving in the capacity of a
designated representative for only one applicant at a time, except where more than one licensed wholesale distributor is co-located in the same facility and such wholesale distributors are members of an affiliated group, as defined in Section 1504 of the Internal Revenue Code.
(e) If a wholesale distributor distributes prescription drugs from more than one facility, the wholesale distributor shall obtain a license for each facility.
(f) The information provided under this Section may not be disclosed to any person or entity other than the Department or another government entity in need of such information for licensing or monitoring purposes.
Sec. 26.
Unlicensed practice; violation; civil penalty.
(a) Any person who practices, offers to practice, attempts to practice, or
holds oneself out to practice as a wholesale drug distributor or pharmacy
distributor without being licensed to ship into, out of, or within the State under this Act shall, in
addition to any other penalty provided by law, pay a civil penalty to the
Department in an amount not to exceed $10,000 for each offense as determined by
the Department. The civil penalty shall be assessed by the Department after a
hearing is held in accordance with the provisions set forth in this Act
regarding the provision of a hearing for the discipline of a licensee.
(b) The Department has the authority and power to investigate any and all
unlicensed activity.
(c) The civil penalty shall be paid within 60 days after the effective date
of the order imposing the civil penalty. The order shall constitute a judgment
and may be filed and execution had thereon in the same manner as any judgment
from any court of record.
Sec. 27.
Social Security Number on license application.
In addition
to any other information required to be contained in the application, every
application for an original license under this Act shall
include the applicant's Social Security Number, which shall be retained in the agency's records pertaining to the license. As soon as practical, the Department shall assign a customer's identification number to each applicant for a license.
Every application for a renewal or restored license shall require the applicant's customer identification number.
(Source: P.A. 97-400, eff. 1-1-12
(from Ch. 111, par. 8301-30)
Sec. 30.
License renewal application procedures.
Application blanks
for renewal of any license required by this Act shall be mailed to each
licensee at least 60 days before the license expires. If the application
for renewal with the required fee is not received by the Department before
the expiration date, the existing license shall lapse and become null and
void. Failure to renew before the expiration date is cause for a late
payment penalty, discipline, or both.
(from Ch. 111, par. 8301-35)
Sec. 35.
Fees; Illinois State Pharmacy Disciplinary Fund.
(a) The Department shall provide by rule for a schedule of fees for the
administration and
enforcement of this Act, including but not limited to original licensure,
renewal, and
restoration. The fees shall be nonrefundable.
(b) All fees collected under this Act shall be deposited into the Illinois
Disciplinary Fund and shall be appropriated to the Department for the ordinary
contingent expenses of the Department in the administration of this Act. Moneys in the Fund may be transferred to the Professions
Indirect Cost Fund as authorized by Section 2105-300 of the
Department of Professional Regulation Law (20 ILCS 2105/2105-300).
The moneys deposited into the Illinois State Pharmacy Disciplinary Fund shall
be invested to earn interest which shall accrue to the Fund.
The Department shall present to the Board for its review and comment all
appropriation requests from the Illinois State Pharmacy Disciplinary Fund. The
Department shall give due consideration to any comments of the Board in making
appropriation requests.
(c) Any person who delivers a check or other payment to the Department that
is returned to the Department unpaid by the financial institution upon
which it is drawn shall pay to the Department, in addition to the amount
already owed to the Department, a fine of $50. The fines imposed by this Section are in addition
to any other discipline provided under this Act for unlicensed
practice or practice on a nonrenewed license. The Department shall notify
the person that payment of fees and fines shall be paid to the Department
by certified check or money order within 30 calendar days of the
notification. If, after the expiration of 30 days from the date of the
notification, the person has failed to submit the necessary remittance, the
Department shall automatically terminate the license or certificate or deny
the application, without hearing. If, after termination or denial, the
person seeks a license or certificate, he or she shall apply to the
Department for restoration or issuance of the license or certificate and
pay all fees and fines due to the Department. The Department may establish
a fee for the processing of an application for restoration of a license or
certificate to pay all expenses of processing this application. The Director
may waive the fines due under this Section in individual cases where the
Director finds that the fines would be unreasonable or unnecessarily
(d) The Department shall maintain a roster of the names and addresses of
all registrants and of all persons whose licenses have been suspended or
revoked. This roster shall be available upon written request and payment of
the required fee.
(e) A manufacturer of controlled substances or wholesale distributor of controlled substances that is licensed under this Act and owned and operated by the State is exempt from licensure, registration, renewal, and other fees required under this Act. Nothing in this subsection (e) shall be construed to prohibit the Department
from imposing any fine or other penalty allowed under this Act.
(from Ch. 111, par. 8301-40)
Sec. 40.
Rules and regulations.
The Department shall
make any rules and regulations, not inconsistent with law, as may be
necessary to carry out the purposes and enforce the provisions of this Act.
Rules and regulations that incorporate and set detailed standards for
meeting each of the license prerequisites set forth in Section 25 of this
Act shall be adopted no later than September 14, 1992.
All rules and regulations promulgated under this Section shall
conform to wholesale drug distributor licensing guidelines formally adopted
by the FDA at 21 C.F.R. Part 205. In case of conflict between any rule
or regulation adopted by the Department and any FDA wholesale drug
distributor guideline, the FDA guideline shall control.
Sec. 45.
(Source: P.A. 87-594. Repealed by P.A. 95-689, eff. 10-29-07.)
(from Ch. 111, par. 8301-50)
Sec. 50.
Inspection powers; access to records.
(a) Any pharmacy investigator authorized by the Department
has the right of entry for inspection during normal business hours
of premises purporting or appearing to be used by a wholesale
drug distributor in this State, including the business premises of a person licensed pursuant to this Act. This right of entry shall permit the authorized pharmacy investigator unfettered access to the entire business premises. Any attempt to hinder an authorized pharmacy investigator from inspecting the business premises and documenting the inspection shall be a violation of this Act. The duly authorized investigators shall be
required to show appropriate identification before being given access to a
wholesale drug distributor's premises and delivery vehicles.
(b) With the exception of the most recent 12 months of records that must be kept on the premises where the drugs are stored, wholesale drug distributors may keep records regarding purchase and
sales transactions electronically at a central location apart from the principal office of
the wholesale drug distributor or the location at which the drugs were
stored and from which they were shipped, provided that the records shall
be made readily available for inspection within 2 working days of a request by the
Department. The records may be kept in any form permissible under federal
law applicable to prescription drugs record keeping.
(c) (Blank).
(from Ch. 111, par. 8301-55)
Sec. 55.
Discipline; grounds.
(a) The Department may refuse to issue, restore, or renew, or may revoke,
suspend, place on probation, reprimand or take other disciplinary or non-disciplinary action as
the Department may deem appropriate, including imposing fines not to exceed $10,000 for each violation, with regard to any applicant or licensee or any officer, director, manager, or shareholder who owns 5% or more interest in the business that holds the license for any one or a combination of the following reasons:
(1) Violation of this Act or of the rules adopted
under this Act.
(2) Aiding or assisting another person in violating
any provision of this Act or the rules adopted under this Act.
(3) Failing, within 60 days, to provide information
in response to a written requirement made by the Department.
(4) Engaging in dishonorable, unethical, or
unprofessional conduct of a character likely to deceive, defraud, or harm the public. This includes violations of "good faith" as defined by the Illinois Controlled Substances Act and applies to all prescription drugs.
(5) Discipline by another U.S. jurisdiction or
foreign nation, if at least one of the grounds for the discipline is the same or substantially equivalent to those set forth in this Act.
(6) Selling or engaging in the sale of drug samples
provided at no cost by drug manufacturers.
(7) Conviction by plea of guilty or nolo contendere,
finding of guilt, jury verdict, or entry of judgment or by sentencing of any crime, including, but not limited to, convictions, preceding sentences of supervision, conditional discharge, or first offender probation, under the laws of any jurisdiction of the United States that is (i) a felony or (ii) a misdemeanor, an essential element of which is dishonesty or that is directly related to the practice of this profession.
(8) Habitual or excessive use or addiction to
alcohol, narcotics, stimulants, or any other chemical agent or drug by the designated representative, as provided for in item (7) of subsection (b) of Section 25 of this Act, any officer, or director that results in the inability to function with reasonable judgment, skill, or safety.
(9) Material misstatement in furnishing information
to the Department.
(10) A finding by the Department that the licensee,
after having his or her license placed on probationary status, has violated the terms of probation.
(11) Fraud or misrepresentation in applying for, or
procuring, a license under this Act or in connection with applying for renewal of a license under this Act.
(12) Willfully making or filing false records or
(13) A finding of a substantial discrepancy in a
Department audit of a prescription drug, including a controlled substance as that term is defined in this Act or in the Illinois Controlled Substances Act.
(14) Falsifying a pedigree or selling, distributing,
transferring, manufacturing, repackaging, handling, or holding a counterfeit prescription drug intended for human use.
(15) Interfering with a Department investigation.
(16) Failing to adequately secure controlled
substances or other prescription drugs from diversion.
(17) Acquiring or distributing prescription drugs not
obtained from a source licensed by the Department.
(18) Failing to properly store drugs.
(19) Failing to maintain the licensed premises with
proper storage and security controls.
(b) The Department may refuse to issue or may suspend the license or
registration of any person who fails to file a return, or to pay the tax,
penalty or interest shown in a filed return, or to pay any final assessment
of tax, penalty or interest, as required by any tax Act administered by the
Illinois Department of Revenue, until the time the requirements of
the tax Act are satisfied.
(c) The Department shall revoke the license or certificate of
registration issued under this Act or any prior Act of
this State of any person who has been convicted a second time of committing
any felony under the Illinois Controlled Substances Act or the Methamphetamine Control and Community Protection Act
or who
has been convicted a second time of committing a Class 1 felony under
Sections 8A-3 and 8A-6 of the Illinois Public Aid Code. A
person whose license or certificate of registration issued under
this Act or any prior Act of this State is revoked under this
subsection (c) shall be prohibited from engaging in the practice of
pharmacy in this State.
(Source: P.A. 97-804, eff. 1-1-13; 97-813, eff. 7-13-12; 98-463, eff. 8-16-13.)
Sec. 56.
Restrictions on transactions.
(a) A licensee shall receive prescription drug returns or exchanges from a pharmacy or other persons authorized to administer or dispense drugs or a chain pharmacy warehouse pursuant to the terms and conditions of the agreement between the wholesale distributor and the pharmacy or chain pharmacy warehouse. Returns of expired, damaged, recalled, or otherwise non-saleable pharmaceutical products shall be distributed by the receiving wholesale distributor only to either the original manufacturer or a third party returns processor. Returns or exchanges of prescription drugs, saleable or otherwise, including any redistribution by a receiving wholesaler, shall not be subject to the pedigree requirements of Section 57 of this Act, so long as they are exempt from the pedigree requirement of the FDA's currently applicable Prescription Drug Marketing Act guidance. Both licensees under this Act and pharmacies or other persons authorized to administer or dispense drugs shall be accountable for administering their returns process and ensuring that the aspects of this operation are secure and do not permit the entry of adulterated and counterfeit product.
(b) A manufacturer or wholesale distributor licensed under this Act may furnish prescription drugs only to a person licensed by the appropriate state licensing authorities.
Before furnishing prescription drugs to a person not known to the manufacturer or wholesale distributor, the manufacturer or wholesale distributor must affirmatively verify that the person is legally authorized to receive the prescription drugs by contacting the appropriate state licensing authorities.
(c) Prescription drugs furnished by a manufacturer or wholesale distributor licensed under this Act may be delivered only to the premises listed on the license, provided that the manufacturer or wholesale distributor may furnish prescription drugs to an authorized person or agent of that person at the premises of the manufacturer or wholesale distributor if:
(1) the identity and authorization of the recipient
is properly established; and
(2) this method of receipt is employed only to meet
the immediate needs of a particular patient of the authorized person.
(d) Prescription drugs may be furnished to a hospital pharmacy receiving area, provided that a pharmacist or authorized receiving personnel signs, at the time of delivery, a receipt showing the type and quantity of the prescription drug received. Any discrepancy between the receipt and the type and quantity of the prescription drug actually received shall be reported to the delivering manufacturer or wholesale distributor by the next business day after the delivery to the pharmacy receiving area.
(e) A manufacturer or wholesale distributor licensed under this Act may not accept payment for, or allow the use of, a person or entity's credit to establish an account for the purchase of prescription drugs from any person other than the owner of record, the chief executive officer, or the chief financial officer listed on the license of a person or entity legally authorized to receive the prescription drugs. Any account established for the purchase of prescription drugs must bear the name of the licensee. This subsection (e) shall not be construed to prohibit a pharmacy or chain pharmacy warehouse from receiving prescription drugs if payment for the prescription drugs is processed through the pharmacy's or chain pharmacy warehouse's contractual drug manufacturer or wholesale distributor.
Sec. 57.
(a) Each person who is engaged in the wholesale distribution of prescription drugs, including repackagers, but excluding the original manufacturer of the finished form of the prescription drug, that leave or have ever left the normal distribution channel shall, before each wholesale distribution of the drug, provide a pedigree to the person who receives the
drug. A retail pharmacy, mail order pharmacy, or chain pharmacy warehouse must comply with the requirements of this Section only if the pharmacy or chain pharmacy warehouse engages in the wholesale distribution of prescription drugs. On or before July 1, 2009, the Department shall determine a targeted implementation date for electronic track and trace pedigree technology. This targeted implementation date shall not be sooner than July 1, 2010. Beginning on the date established by the Department, pedigrees may be implemented through an approved and readily available system that electronically tracks and traces the wholesale distribution of each prescription drug starting with the sale by the manufacturer through acquisition and sale by any wholesale distributor and until final sale to a pharmacy or other authorized person administering or dispensing the prescription drug. This electronic tracking system shall be deemed to be readily available only upon there being available a standardized system originating with the manufacturers and capable of being used on a wide scale across the entire pharmaceutical chain, including manufacturers, wholesale distributors, and pharmacies. Consideration must also be given to the large-scale implementation of this technology across the supply chain and the technology must be proven to have no negative impact on the safety and efficacy of the pharmaceutical product.
(b) Each person who is engaged in the wholesale distribution of a prescription drug who is provided a pedigree for a prescription drug and attempts to further distribute that prescription drug, including repackagers, but excluding the original manufacturer of the finished form of the prescription drug, must affirmatively verify before any distribution of a prescription drug occurs that each transaction listed on the pedigree has occurred.
(c) The pedigree must include all necessary identifying information concerning each sale in the chain of distribution of the product from the manufacturer or the manufacturer's third party logistics provider, co-licensed product partner, or exclusive distributor through acquisition and sale by any wholesale distributor or repackager, until final sale to a pharmacy or other person dispensing or administering the drug. This necessary chain of distribution information shall include, without limitation all of the following:
(1) The name, address, telephone number and, if
available, the e-mail address of each owner of the prescription drug and each wholesale distributor of the prescription drug.
(2) The name and address of each location from which
the product was shipped, if different from the owner's.
(3) Transaction dates.
(4) Certification that each recipient has
authenticated the pedigree.
(d) The pedigree must also include without limitation all of the following information concerning the prescription drug:
(1) The name and national drug code number of the
prescription drug.
(2) The dosage form and strength of the prescription
(3) The size of the container.
(4) The number of containers.
(5) The lot number of the prescription drug.
(6) The name of the manufacturer of the finished
dosage form.
(e) Each pedigree or electronic file shall be maintained by the purchaser and the wholesale distributor for at least 3 years from the date of sale or transfer and made available for inspection or use within 5 business days upon a request of the Department.
Sec. 58.
Prohibited acts.
It is unlawful for a person to perform or cause the performance of or aid and abet any of the following acts:
(1) Failure to obtain a license in accordance with
this Act or operating without a valid license when a license is required by this Act.
(2) If the requirements of subsection (a) of Section
56 of this Act are applicable and are not met, the purchasing or otherwise receiving of a prescription drug from a pharmacy.
(3) If licensure is required pursuant to subsection
(b) of Section 56 of this Act, the sale, distribution, or transfer of a prescription drug to a person that is not authorized under the law of the jurisdiction in which the person receives the prescription drug to receive the prescription drug.
(4) Failure to deliver prescription drugs to
specified premises, as required by subsection (c) of Section 56 of this Act.
(5) Accepting payment or credit for the sale of
prescription drugs in violation of subsection (e) of Section 56 of this Act.
(6) Failure to maintain or provide pedigrees as
required by this Act.
(7) Failure to obtain, pass, or authenticate a
pedigree as required by this Act.
(8) Providing the Department or any federal official
with false or fraudulent records or making false or fraudulent statements regarding any matter within the provisions of this Act.
(9) Obtaining or attempting to obtain a prescription
drug by fraud, deceit, or misrepresentation or engaging in misrepresentation or fraud in the distribution of a prescription drug.
(10) The manufacture, repacking, sale, transfer,
delivery, holding, or offering for sale of any prescription drug that is adulterated, misbranded, counterfeit, suspected of being counterfeit, or that has otherwise been rendered unfit for distribution, except for the wholesale distribution by manufacturers of a prescription drug that has been delivered into commerce pursuant to an application approved under federal law by the FDA.
(11) The adulteration, misbranding, or counterfeiting
of any prescription drug, except for the wholesale distribution by manufacturers of a prescription drug that has been delivered into commerce pursuant to an application approved under federal law by the FDA.
(12) The receipt of any prescription drug that is
adulterated, misbranded, stolen, obtained by fraud or deceit, counterfeit, or suspected of being counterfeit and the delivery or proffered delivery of such drug for pay or otherwise.
(13) The alteration, mutilation, destruction,
obliteration, or removal of the whole or any part of the labeling of a prescription drug or the commission of any other act with respect to a prescription drug that results in the prescription drug being misbranded. The acts prohibited in this Section do not include the obtaining or the attempt to obtain a prescription drug for the sole purpose of testing the prescription drug for authenticity performed by a prescription drug manufacturer or the agent of a prescription drug manufacturer.
Sec. 59.
Injunctive action; cease and desist order.
(a) If any person violates the provisions of this Act, the Secretary, in the name of the People of the State of Illinois, through the Attorney General or the State's Attorney of the county where the violation is alleged to have occurred, may petition for an order enjoining the violation or for an order enforcing compliance with this Act. Upon the filing of a verified petition, the court with appropriate jurisdiction may issue a temporary restraining order, without notice or bond, and may preliminarily and permanently enjoin the violation. If it is established that the person has violated or is violating the injunction, then the court may punish the offender for contempt of court. Proceedings under this Section are in addition to, and not in lieu of, all other remedies and penalties provided by this Act.
(b) Whenever, in the opinion of the Department, a person violates any provision of this Act, the Department may issue a rule to show cause why an order to cease and desist shall not be entered against that person. The rule shall clearly set forth the grounds relied upon by the Department and shall allow a person at least 7 days after the date of the rule to file an answer satisfactory to the Department. Failure to answer to the satisfaction of the Department shall cause an order to cease and desist to be issued.
(from Ch. 111, par. 8301-60)
Sec. 60.
Wholesaler licensing; complaints.
The Department may refuse
to issue a license to establish a new licensed wholesale drug
distributorship, if an owner of the wholesale drug distributorship applying
for a license was an owner of a wholesale drug distributorship that had its
license revoked, unless the owner presents sufficient evidence indicating
rehabilitation. Once a complaint has been filed by the Department against
a wholesale drug distributorship the Department may refuse to issue a
license to establish a new licensed wholesale drug distributorship,
until such time as the Department issues a decision on the complaint if an
owner of the new wholesale drug distributorship was also an owner of a
wholesale drug distributorship against which the complaint was filed.
Neither an application for change of ownership nor for a change of location
for any such wholesale drug distributorship shall be acted on by the
Department until such time as the Department issues a decision on the
complaint. In the event that the wholesale drug distributorship against
which the complaint has been filed ceases to be licensed by the Department,
for any reason, before the Department's decision on the complaint and an
owner or that wholesale drug distributorship applies for a license to
establish a new wholesale drug distributorship, the Department shall
conduct a hearing on the complaint earlier filed, regardless of whether
that wholesale drug distributorship is presently licensed by the
Department. If the conduct for which the complaint was originally filed
would have been sufficient to result in a revocation of a license to
operate a licensed wholesale drug distributorship, then the conduct shall
constitute sufficient grounds for denial of an application for a license.
(from Ch. 111, par. 8301-65)
Sec. 65.
Pending disciplinary proceeding.
The Department
shall render no final administrative decision relative to any
application for a license or certificate of registration under
this Act if the applicant for the license or certificate of
registration is the subject of a pending disciplinary proceeding
under this Act or another Act administered by the Department. For
purposes of this Section "applicant" means an individual or sole
proprietor, or an individual who is an officer, director, or owner
of a 5% or more beneficial interest in the applicant.
(from Ch. 111, par. 8301-70)
Sec. 70.
Immediate suspension of license or registration; hearing.
The Director may, upon receipt of a written communication
from the Secretary of Human Services or the Director of Public Health that
continuation of practice
of a person licensed or registered under this Act constitutes an immediate
danger to the public, immediately suspend the license or registration of
that person without a hearing. In instances in which the Director
immediately suspends a license or registration under this Section, a hearing
upon the person's license must be convened by the Board within 15 days
after the suspension and completed without appreciable delay. The hearing
shall be held to determine whether to recommend to the Director that the
person's license be revoked, suspended, placed on probationary status, or
reinstated, or that the person be subject to other disciplinary action. In
the hearing, the written communication and any other evidence submitted
with the communication may be introduced as evidence
against the person. The person or his or her counsel shall
have the opportunity to discredit or impeach such evidence and submit
rebuttal evidence.
(Source: P.A. 89-507, eff. 7-1-97
(from Ch. 111, par. 8301-75)
Sec. 75.
Automatic suspension.
The determination by a
circuit court that a licensee is subject to involuntary
admission or judicial admission as provided in the Mental
Health and Developmental Disabilities Code operates as an
automatic suspension. The suspension shall end only upon (i)
a finding by a court that the patient is no longer subject
to involuntary admission or judicial admission and the issuance
of an order so finding and discharging the patient and (ii) the
recommendation of the Board to the Director that the licensee
be allowed to resume his or her practice.
(Source: P.A. 91-357, eff. 7-29-99
(from Ch. 111, par. 8301-80)
Sec. 80.
Violations of Act.
(a) If any person violates the provisions of this Act, the
Director may, in the name of the People of the State of Illinois through
the Attorney General of the State of Illinois or the State's Attorney of
any county in which the action is brought, petition for an order enjoining
the violation or for an order enforcing compliance with this Act. Upon
the filing of a verified petition in the court, the court may issue a
temporary restraining order, without notice or bond, and may preliminarily
and permanently enjoin the violation. If it is established that the
person has violated or is violating the injunction, the Court may punish
the offender for contempt of court. Proceedings under this Section shall
be in addition to, and not in lieu of, all other remedies and penalties
provided by this Act.
(b) Whoever knowingly conducts business as a wholesale drug distributor
in this State without being appropriately licensed under this Act shall be
guilty of a Class A misdemeanor for a first violation and for each
subsequent conviction shall be guilty of a Class 4 felony.
(c) Whenever in the opinion of the Department any person not licensed in
good standing under this Act violates any provision of this Act, the
Department may issue a rule to show cause why an order to cease and desist
should not be entered against him. The rule shall clearly set forth the
grounds relied upon by the Department and shall provide a period of 7 days
from the date of the rule to file an answer to the satisfaction of the
Department. Failure to answer to the satisfaction of the Department shall
cause an order to cease and desist to be issued immediately.
(from Ch. 111, par. 8301-85)
Sec. 85.
Investigations; notice of disciplinary hearing.
Department may investigate the actions of any applicant or of any person or
persons holding or claiming to hold a license or registration. Before
suspending, revoking, placing on probationary status, or taking any other
disciplinary action as the Department may deem proper with regard to any
license or certificate, at least 30 days before the date set for the
hearing, the Department shall (i) notify the accused in writing of any
charges made and the time and place for a hearing of the charges before
the Board, (ii) direct him or her to file a written answer to the charges
with the Board under oath within 20 days after the service of the notice,
and (iii) inform the accused that if he or she fails to file an answer
default will be taken against him or her and his or her license or
certificate may be suspended, revoked, placed on probationary
status, or have other disciplinary action, including limiting the scope,
nature or extent of business, as provided for in this Act. The written notice
may be served by personal delivery or certified or registered mail to the
respondent at the address of last notification to the Department. At
the time and place fixed in the notice, the Board shall proceed to hear the
charges and the parties or their counsel shall be accorded ample
opportunity to present any statements, testimony, evidence and argument
that may be pertinent to the charges or to their defense. The hearing may
be continued from time to time. In case the accused person, after
receiving notice, fails to file an answer, his or her license or
certificate may in the discretion of the Director, having received first
the recommendation of the Board, be suspended, revoked, placed on
probationary status, or the Director may take whatever disciplinary action
as he or she may deem proper as provided in this Act, including limiting
the scope, nature, or extent of the person's practice, without a hearing,
if the act or acts charged constitute sufficient grounds for such action
under this Act.
(from Ch. 111, par. 8301-90)
Sec. 90.
Record of proceedings.
The Department, at its expense,
shall preserve a record of all proceedings at the formal hearing of any
case involving the refusal to issue or renew a license or discipline of a
licensee. The notice of hearing, complaint, and all other documents in the
nature of pleadings and written motions filed in the proceedings, the
transcript of testimony, the report of the Board or hearing officer, and
orders of the Department shall be the record of the proceeding.
(from Ch. 111, par. 8301-95)
Sec. 95.
Order requiring attendance of witnesses and production of
evidence. Any circuit court may, upon application of the Department or its
designee or of the applicant or licensee against whom proceedings of this
Act are pending, enter an order requiring the attendance of witnesses and
their testimony and the production of documents, papers, files, books and
records in connection with any hearing or investigation. The court may
compel obedience to its order by proceedings for contempt.
(from Ch. 111, par. 8301-100)
Sec. 100.
Subpoena power; administration of oaths.
The Department
shall have power to subpoena and bring before it any person in this State
and to take testimony, either orally or by deposition or both, with the
same fees and mileage and in the same manner as prescribed by law in
judicial proceedings in civil cases in circuit courts of this State.
The Director and any member of the Board shall each have power to
administer oaths to witnesses at any hearing which the Department is
authorized to conduct under this Act, and any other oaths required or
authorized to be administered by the Department under this Act.
(from Ch. 111, par. 8301-105)
Sec. 105.
Report of findings and recommendation.
At the conclusion
of the hearing, the Board shall present to the Director a written report of
its findings of fact, conclusions of law, and recommendations. The report
shall contain a finding whether or not the accused person violated this Act
or failed to comply with the conditions required in this Act. The Board
shall specify the nature of the violation or failure to comply and shall
make its recommendations to the Director.
The report of findings of fact, conclusion of law, and recommendations of
the Board shall be the basis for the Department's order for refusal or for
the granting of a license or registration. The finding is not admissible
in evidence against the person in a criminal prosecution brought for the
violation of this Act, but the hearing and finding are not a bar to a
criminal prosecution brought for the violation of this Act.
(from Ch. 111, par. 8301-110)
Sec. 110.
Hearing officers; appointment.
Notwithstanding any other
provision of this Act, the Director shall have the authority to appoint
any attorney duly licensed to practice law in the State of Illinois to
serve as the hearing officer in any action before the Board for refusal to
issue or renew a license, or the discipline of a licensee. The Director
shall notify the Board of any such appointment. The hearing officer shall
have full authority to conduct the hearing. There shall be present at
least one member of the Board at any such hearing. The hearing officer
shall report his findings of fact, conclusions of law, and recommendations
to the Board and the Director. The Board shall have 60 days from receipt
of the report to review the report of the hearing officer and present its
findings of fact, conclusions of law, and recommendations to the Director.
If the Board fails to present its report within the 60 day period, the
Director may issue an order based on report of the hearing officer.
However, if the Board does present its report within the specified 60 days,
the Director's order shall be based upon the report of the Board.
(from Ch. 111, par. 8301-115)
Sec. 115.
Motion for rehearing.
In any case involving the refusal to
issue, renew, or discipline of a license or registration, a copy of the
Board's report shall be served upon the respondent by the Department, either
personally or as provided in this Act for the service of the notice of
hearing. Within 20 days after service, the respondent may present to
the Department a motion in writing for a rehearing, which shall
specify the particular grounds for rehearing. If no motion for rehearing is
filed, then upon the expiration of the time specified for filing a
motion, or if a motion for rehearing is denied, then upon denial the
Director may enter an order in accordance with recommendations of the Board.
If the respondent orders from the reporting service and
pays for a transcript of the record within the time for filing a motion
for rehearing, the 20 day period within which a motion may be filed shall
commence upon the delivery of the transcript to the respondent.
(from Ch. 111, par. 8301-120)
Sec. 120.
Rehearing by order of Director.
Whenever the Director is
satisfied that substantial justice has not been done in the revocation,
suspension, or refusal to issue or renew a license or registration,
the Director may order a rehearing by the same hearing office or Board.
(from Ch. 111, par. 8301-125)
Sec. 125.
Board recommendations to Director; disagreement.
None of
the disciplinary functions, powers, and duties enumerated in this Act shall
be exercised by the Department except upon the action and report in writing
of the Board, except as otherwise provided in this Act.
In all instances under this Act in which the Board has rendered a
recommendation to the Director with respect to a particular license or
certificate, the Director shall, in the event that he or she disagrees with or
takes action contrary to the recommendation of the Board, file with the
Board and Secretary of State his or her specific written reasons for
disagreement with the Board. These reasons shall be filed within 30 days
after the Director taking the contrary position.
The action and report in writing of a majority of the Board is
sufficient authority upon which the Director may act.
(from Ch. 111, par. 8301-130)
Sec. 130.
State liability for disciplinary action without reasonable
In the event that the Department's order of revocation, suspension,
placing the licensee on probationary status, or other order or formal
disciplinary action is without any reasonable basis, then the State of
Illinois shall be liable to the injured party for those special damages
suffered as a direct result of such order.
(from Ch. 111, par. 8301-135)
Sec. 135.
Disciplinary consent orders.
Notwithstanding the provisions
of this Act concerning the conduct of hearings and recommendations for
disciplinary actions, the Director shall have the authority to negotiate
agreements with licensees and registrants resulting in disciplinary consent
orders. Consent orders may provide for any of the forms of discipline
otherwise provided in this Act. Consent orders shall provide that they were
not entered into a result of any coercion by the Department. The Director
shall forward copies of all final consent orders to the Board within 30
days after their entry.
(from Ch. 111, par. 8301-140)
Sec. 140.
Orders; prima facie proof.
An order or a certified copy
thereof, over the seal of the Department and purporting to be signed by the
Director, shall be prima facie proof that:
(a) the signature is the genuine signature of the
(b) the Director is duly appointed and qualified; and
(c) the Board and its members are qualified to act.
(from Ch. 111, par. 8301-145)
Sec. 145.
Restoration of certificate.
At any time after suspension
or revocation of any certificate, the Department may restore it to the
accused person upon the written recommendation of the Board.
(from Ch. 111, par. 8301-150)
Sec. 150.
Surrender of license or registration.
Upon the revocation
or suspension of any license or registration, the holder shall immediately
surrender the license or registration to the Department and if the
licensee fails to do so, the Department shall have the right to seize the
license or certificate.
(from Ch. 111, par. 8301-155)
Sec. 155.
Temporary suspension of license; hearing.
The Director
may temporarily suspend licensure as a wholesale drug distributor,
without a hearing, simultaneously with the institution of proceedings for a
hearing provided for in Section 85 of this Act, if the Director finds that
evidence in his or her possession indicates that a continuation in business
would constitute an imminent danger to the public. In the event that the
Director temporarily suspends a license or certificate without a
hearing, a hearing by the Department must be held within 10 days after
the suspension has occurred and be concluded without appreciable delay.
(from Ch. 111, par. 8301-160)
Sec. 160.
Administrative Review Law; venue.
All final
administrative decisions of the Department are subject to judicial
review under the Administrative Review Law and its rules. The
term "administrative decision" is defined as in Section 3-101
of the Code of Civil Procedure.
Proceedings for judicial review shall be commenced in the circuit
court of the county in which the party applying for review resides;
but if the party is not a resident of this State, the venue shall be
in Sangamon County.
(from Ch. 111, par. 8301-165)
Sec. 165.
Certification of record; receipt for costs.
Department shall not be required to certify any record to the court or file
any answer in court or otherwise appear in any court in a judicial review
proceeding, unless there is filed in the court, with the complaint, a
receipt from the Department acknowledging payment of the costs of
furnishing and certifying the record, which costs shall be computed at the
rate of 25 cents per page of such record. Failure on the part of the
plaintiff to file a receipt in court shall be grounds for dismissal of
the action.
(from Ch. 111, par. 8301-170)
Sec. 170.
Any person who is found to have violated
any provision of this Act is guilty of a Class A misdemeanor. On
conviction of a second or subsequent offense, the violator shall
be guilty of a Class 4 felony. All criminal fines, monies, or
property collected or received by the Department under this Section
or any other State or federal statute, including, but not limited
to, property forfeited to the Department under Section 505 of the
Illinois Controlled Substances Act or Section 85 of the Methamphetamine Control and Community Protection Act, shall be deposited into the
Professional Regulation Evidence Fund.
(Source: P.A. 94-556, eff. 9-11-05
Sec. 173.
All information collected by the Department in the course of an examination or investigation of a licensee or applicant, including, but not limited to, any complaint against a licensee filed with the Department and information collected to investigate any such complaint, shall be maintained for the confidential use of the Department and shall not be disclosed. The Department may not disclose the information to anyone other than law enforcement officials, other regulatory agencies that have an appropriate regulatory interest as determined by the Secretary, or a party presenting a lawful subpoena to the Department. Information and documents disclosed to a federal, State, county, or local law enforcement agency shall not be disclosed by the agency for any purpose to any other agency or person. A formal complaint filed against a licensee by the Department or any order issued by the Department against a licensee or applicant shall be a public record, except as otherwise prohibited by law.
(from Ch. 111, par. 8301-175)
Sec. 175.
Administrative procedure.
The Illinois Administrative
Procedure Act is hereby expressly adopted and incorporated as if the
provisions of that Act were included in this Act, except that the
provision of paragraph (d) of Section 10-65 of the
Illinois Administrative Procedure Act, which provides that at hearings the
licensee has the right to show compliance with all lawful requirements for
retention, continuation, or renewal of the license, is
specifically excluded. For the purpose of this Act, the notice required
under Section 10-25 of the Administrative Procedure Act is
deemed sufficient when mailed to the last known address of a party.
(Source: P.A. 87-594; 88-670, eff. 12-2-94
(from Ch. 111, par. 8301-180)
Sec. 180.
Conflict of laws.
In the event of a conflict between any
provision of this Act and the Mental Health and Developmental Disabilities
Confidentiality Act, the provisions of this Act shall govern.
(from Ch. 111, par. 8301-185)
Sec. 185.
Home rule preemption.
The regulation and licensing of
wholesale drug distributors are exclusive powers and functions of the
State. A home rule unit may not regulate or license wholesale drug
distributors. This Section is a denial and limitation of home rule powers
and functions under subsection (h) of Section 6 of Article VII of the
Illinois Constitution.
(from Ch. 111, par. 8301-195)
Sec. 195.
Effective date.
This Act shall take effect upon becoming law.
Sec. 200.
Drugs in shortage.
(a) For the purpose of this Section, "drug in shortage" means a drug, as defined in Section 356c of the Federal Food, Drug, and Cosmetic Act, listed on the drug shortage list maintained by the U.S. Food and Drug Administration in accordance with Section 356e of the Federal Food, Drug, and Cosmetic Act.
(b) Any person engaged in the wholesale distribution of a drug in shortage in this State must be licensed by the Department.
(c) It is unlawful for any person, other than a manufacturer, a manufacturer's exclusive distributor, a third party logistics provider, or an authorized distributor of record, to purchase or receive a drug in shortage from any person not licensed by the Department. This subsection (c) does not apply to the return of drugs or the purchase or receipt of drugs pursuant to any of the distributions that are specifically excluded from the definition of "wholesale distribution" in Section 15 of the Wholesale Drug Distribution Licensing Act.
(d) A person found to have violated a provision of this Section shall be subject to administrative fines, orders for restitution, and orders for disgorgement.
(e) The Department shall create a centralized, searchable database of those entities licensed to engage in wholesale distribution, including manufacturers, wholesale distributors, and pharmacy distributors, to enable purchasers of a drug in shortage to easily verify the licensing status of an entity offering such drugs.
(f) The Department shall establish a system for reporting the reasonable suspicion that a violation of this Act has been committed by a distributor of a drug in shortage. Reports made through this system shall be referred to the Office of the Attorney General and the appropriate State's Attorney's office for further investigation and prosecution.
(g) The Department shall adopt rules to carry out the provisions of this Section.
(h) Nothing in this Section prohibits one hospital pharmacy from purchasing or receiving a drug in shortage from another hospital pharmacy in the event of a medical emergency.
(Source: P.A. 98-355, eff. 8-16-13.)


text:
A Letter to the Editor in the 1/31/06 Tomahawk Leader
To the Editor:
Not long ago Mr. Dave Obey breezed through town on a "fact finding" campaign trip. During the discussion the old "Tax Cuts for the Rich" mantra was thrown out. Sad to say a lot of people attending bought into the deception. The fact is in spite of across-the-board tax cuts the federal government reported that tax revenues collected in September were the highest ever in the history of the United States, proving the theory that tax cuts = more spending = more jobs = more tax revenue. In addition, the increase in Child Tax Credit meant that some people who pay no taxes at all received a larger check back from the government. That doesn't sound like tax cuts for the rich to me.
Among our elected representatives are some of the wealthiest people in the country. If they feel so guilty about voting themselves tax cuts then perhaps they would be willing to make additional voluntary contributions to the IRS. Maybe then we will find out how serious they are about taking care of us "little people."
In this time of heated election rhetoric we must try to cut through all the mud and verbal garbage that is being slung around and find out where the candidates stand on the real issues. The important thing is not what they say about the activities of their opponents, but what they will actually do when they get to office. It's a tough job for the voters, but it is our responsibility to do it.
Tim Blair
Tough job for voters …
Letters to the Editor from the Tomahawk Leader.
1 post • Page 1 of 1
- Administrator
- Posts: 679
- Joined: Tue Jul 31, 2001 1:01 am
- Contact:
1 post • Page 1 of 1
Return to "Letters to the Editor"
Who is online
Users browsing this forum: No registered users and 2 guests


text:
Log in
< Timetable
Body Pump
This session is in the past.
Start Date:
Wednesday, 19 September 2018 at 9:30 AM
60 Minutes
(No Bookings Required)
BodyPump is the original barbell class. BodyPump is one of the world's fastest ways to get in shape as it challenges all of your major muscle groups while you squat, press, lift and curl. This class will sculpt, tone and strengthen your entire body, fast! Focusing on low weight loads and high repetitions, you'll burn fat, gain strength and quickly produce lean body muscle conditioning.
How long is each class? Each traditional class goes for 60 minutes, however try our BodyPump Express class - this 30 minute express format exercises the main
muscle groups fast!
255-257 Colchester Road, Kilsyth, Kilsyth South 3137
(03) 9761 5077
AUS Eastern Standard Time
Privacy Policy
Terms and Conditions
Copyright © 2014 - 2018 - Clubware Ltd. All rights reserved.


text:
Synopsis: Jim Henson ventures into Tolkien territory in his all-Muppet fantasy feature The Dark Crystal. The titular Crystal maintains equilibrium in a mythical kingdom. When the Crystal is broken, the evil Skeksis take over, killing off the good-guy Gelflings and enslaving everyone else. Two of the Gelflings have survived: Jen was raised by the all-knowing Mystics, while Kira grew up amongst the swamp-dwelling Podlings. Jen and Kira join forces to "heal" the precious Dark Crystal and restore order to their world. Adults may find the whole affair a little precious, while children may be disturbed by the film's mortality rate.
Reviews: PopMatters.com | allmovie | Rotten Tomatoes | IMDb (external reviews)
scariest film on this site
...the puppets freak me out. They looks so wrong -- spudthedestroyer @ dead-donkey.com
IMDb: http://www.imdb.com/title/tt0083791/
IMDb Rating: 7.0/10 (13,534 votes)
Tomatometer: 70%
Directed by: Jim Henson & Frank Oz
Jim Henson .... High Priest / Jen
Kathryn Mullen .... Kira
Dave Goelz .... General
Brian Muehl .... Ornamentalist/Dying Master
Kiran Shah .... Stunts
Stephen Garlick .... Jen [Voice]
Lisa Maxwell .... Kira [Voice]
Billie Whitelaw .... Aughra [Voice]
Percy Edwards .... Fizzgig [Voice]
Sean Barrett .... [Voice]
- Code: Select all
Title: The Dark Crystal (1982)
Source: DVD / R2, PAL / Superbit
Size: 1.171.972.578 (1/4 DVDR)
Runtime: 01:29:17
Format: MKV
Video Codec: H264 (x264 rev.1140)
Video Bitrate: 1298 kbps
Resolution: 700x424 (Anamorphic, displayed at 2.35 AR)
Aspect Ratio: 2.35 (SAR: 64/45)
Frame rate: 25 fps
Audio Codec: AC3 (5.1 channels)
Audio Bitrate: 448 kbps
Sampling Rate: 48 KHz
Language: English
Subtitles (muxed in): SRT: English / VobSub: Dutch, Hindi
SA: HP @ Level 4.1
Screenshots resized to displayed AR:


text:
Athlete Of The Year: Nate Hatalsky, Mechanicville
Nate Hatalsky was a little apprehensive about making the switch from nose guard to linebacker as a sophomore in his second varsity season at Mechanicville. He sure did adjust quickly, though.
"It fit me. I felt comfortable there," Hatalsky said.
"We saw some good things in him then, but never suspected he would turn out to be as dominant a player as he is now," Mechanicville coach Kevin Collins said.
After teaming for two years with older brother Chris on the Red Raiders' defense, Hatalsky made sure his final season at Mechanicville was memorable.
"With my brother (Chris) graduating, it pushed me. It made me realize, 'Wow, I've got one more year in this red and white jersey.' There is nothing like playing high school football with your friends," Hatalsky said.
Hatalsky raised his game in 2012, and in Week 2 vs. Tamarac he showed how special his senior season would be: 27 tackles and two sacks in a 12-6 overtime win.
"I knew we needed a win that night, so I felt I had to step up as one of the leaders," Hatalsky said.
"I think that really was a coming-out game for him. He showcased what he is capable of dropping back in coverage and making reads and tackles in the open field," Collins said.
Hatalsky, who is 6-foot-1 and 215 pounds, earned Class C North Defensive Player of the Year honors with 72 solo stops and 64 assisted tackles for the Red Raiders. He also excelled at middle linebacker in the Exceptional Seniors Game.
"He played a fantastic game that night," Collins said. "Nate is one of those players who has a great attitude and a great work ethic. That rubs off on everyone else."
Football defense all-stars (small school)
First team
Athlete of the Year: Nate Hatalsky, Sr. LB, Mechanicville
James Gallup, Sr., Corinth: Led the Tomahawks with 13 sacks and played for the winning North squad at the 2012 Exceptional Seniors game.
Bryan Sherman, Sr., Hoosick Falls: Belied his 5-foot-6, 150-pound frame with a power-speed combination that generated 69 tackles (12 for loss) and six sacks.
More Information
All-star teams schedule
Boys' cross country Nov. 17
Girls' cross country Nov. 18
Golf Nov. 19
Field hockey Nov. 20
Girls' tennis Nov. 21
Girls' soccer (large school) Nov. 22
Girls' soccer (small school) Nov. 23
Boys' soccer (small school) Nov. 24
Boys' soccer (large school) Nov. 25
Girls' swimming Monday
Girls' volleyball Tuesday
Boys' volleyball Wednesday
Football offense (small school) Thursday
Football defense (small school) Friday
Football defense (large school) Saturday
Football offense (large school) Sunday
Alex Buchanan, Sr., Albany Academy: Opponents often double-teamed the 285-pound standout, who earned first-team Reinfurt Division all-star status.
Mike Famolaro, Sr., Schalmont: A fourth-team all-state selection as a junior, Famolaro earned the 2012 West Division Defensive POY award.
Raekwon Ward, Sr., Lansingburgh: Earned first-team Reinfurt Division honors and started in the Exceptional Seniors game.
Ian Bennett, Sr., Albany Academy: The first-team Reinfurt Division choice recorded 41 solo tackles, 36 assisted stops, two sacks and two interceptions.
Al Kelly, Jr., Chatham: The Class C South Defensive Player of the Year, Kelly was in on 100 tackles and registered four sacks.
Dylan Keyer, Sr., Ravena: A three-time first-team Reinfurt Division all-star, Keyer garnered Defensive POY honors as a senior.
James Stevens, Jr., Rensselaer: The Class D South Defensive Player of the Year helped leads the Rams to the state semifinals.
Brandon LaForest, Sr., Cohoes: First-team Reinfurt Division all-star at both receiver and defensive back (20 tackles, eight interceptions).
Brian Pulsifer, Sr., Ichabod Crane: A starter for the South in the Exceptional Seniors game, Pulsifer was a first-team Reinfurt Division selection.
Kevin Twardzik, Sr., Fonda: A first-team Class C South Division all-star, Twardzik led the Braves' secondary with six interceptions.
David Warnken, So., Ravena: The safety, a first-team Reinfurt Division selection, registered 40 solo stops, 25 assisted tackles, seven interceptions and two fumble recoveries.
Kick returner
Winston Lee, Hudson: The Bluehawks won just once in 2012, yet Lee (respected as a running back and returner) played in the Exceptional Senior game.
Shane Lyon, Sr., Schuylerville: Whether it was playing quarterback, defensive back or handling punting duties, Lyon was quite effective.
Second team
DE: Vaughn Chestnut, Sr., Lansingburgh, Shawn Gerkman, Sr., Ichabod Crane, Dan Waldron, Sr., Schuylerville; DT: Zach Bulger, Sr., Broadalbin-Perth, Doug Mark, Jr., Ravena, Harry Proctor, Sr., Schuylerville; LB: Frank Capone, Sr., Watervliet, John Diekel, Sr., Whitehall, Nick Gallo, So., Schalmont, Zac Nowak, Jr., Fonda, Garrett Simmons, Sr. Taconic Hills; DB: Levi Brewster, Jr., Hoosick Falls, Matt Girard, Sr., Glens Falls, Joe Kennedy, Sr., Lansingburgh, Gabe Mendez, Jr., Broadalbin-Perth, Tyler VanBrunt, Jr., Chatham; KR: Rasean Joseph, Sr., Green Tech; P: Jake Sammons, Sr., Fonda.


text:
Poll: How Often Do You Order Deep Dish?
During last week's poll, we had a number of folks point out that the query may as well have been a proxy vote on NYC-style vs. deep dish. (Though we respectfully disagree, because "not deep dish" does not automatically equal "NYC-style" — think of all the other non–deep dish, non–NYC styles out there.) Anyway, there seemed to be some sentiment for a poll to take on the question of how often Chicagoans eat deep dish:
How about a poll for Chicagoans, how often they order deep dish vs thin. Or some variation of that. I like deep dish...about once a decade. Thin crust, though, is a weekly thing. I suspect most Chicagoans would agree. —Garvey
So: How often do order deep dish vs. thin crust? »
(If you're not from Chicago, just pretend....)
This post may contain links to Amazon or other partners; your purchases via these links can benefit Serious Eats. Read more about our affiliate linking policy.


text:
All moderator applicants must be a member for at least 180 days (6 months) and have at least 100 posts. You must be active in the individual forums you wish to moderate and regularly create and respond to threads in those forums. You must also maintain a working knowledge of the subject matter.
Please be aware that applying to be a moderator does not guarantee acceptance and that moderators will only be promoted when needed. Current moderators and administrators will review applications and decide if the applicant fits the desired spot. Administrators have final say and we reserve to right to deny applicants with or without cause.
Accepted applicants may be subject to personal search, a medical exam, and/or branding for advertising purposes. Thank you for your dedication!
The moderator application can be found HERE.


text:
Watch your favorite DVDs on your home theater system, desktop or laptop PC, and enjoy crystal-clear pictures with top audio performance. With broad format support, state-of-the-art enhancement technologies and unique features for watching movies on the go, WinDVD offers the best entertainment experience.
- Enjoy standard DVDs at HD-quality with theater-like surround sound
- Watch movies wherever you are with battery optimization and TimeStretch playback
- Play movies in the most popular audio and video formats
- Instantly hide navigation controls for a clean, sleek look
WinDVD includes support for:
- DVD-Video, DivX®, RealPlayer®, QuickTime®, Windows Media® and AVI support
- Dolby Digital 5.1 Surround Sound
- DTS® audio stereo support
- SRS audio virtual surround and headphone enhancements
- Battery optimization for laptops
- Advanced upscaling
- De-snow and De-block filters
# New design
* Corel WinDVD 11 introduces a redesigned application window with quick and responsive playback controls that provide effortless navigation of discs and other media and easy access to all the main features.
# Blu-ray 3D disc playback
* Corel WinDVD offers the best Blu-ray and HD video playback performance on your PC. With the introduction of new Blu-ray 3D technologies, you can experience high-definition Blu-ray movies in an enthralling 3D environment.
* It accomodates side-by-side playback, and lets you watch streaming 3D video files or videos recorded on Fujifilm 3D camera and other 3D camcorders. It also supports playback of large-capacity BDXL discs, the latest Blu-ray format, which allows users to create 100 GB rewriteable discs.
# 2D to 3D conversion
* Convert your 2D video to 3D on the fly. This technology analyzes the color, position and motion characteristics in 2D video to render stereoscopic 3D views during video playback.
# HD video playback
* Corel WinDVD 11 plays high-definition Blu-ray and other HD movies with stunning 1080p sharpness and next-generation surround sound on your PC. It also supports the playback of BDXL files and HD video from DVD recordable discs with AVCREC and AVCHD support.
# Playback directly from camera or camcorder
* Preview videos on your PC directly from your camera, camcorder or storage device for an instant playback of the event you captured.
# Broad video format support
* Corel WinDVD 11 supports a wide range of video formats from the most common video types, including DVD-Video, QuickTime, Windows Media (WMV), Blu-ray to new file formats such as, DivX, MKV, MTS, M2TS, MP4, 3GP and FLV, and plays back from memory cards or internal camera memory.
# Premium video search
* Corel WinDVD 11 includes FlixFinder, an integrated online movie search engine that lets you find and play premium streaming or downloaded movies and TV shows from partners such as Amazon, Hulu, and Netflix. Tag and search videos by various criteria, compare prices and compile a list of Favorites.
# Video stabilizer
* The video stabilization filter stabilizes excess camera motion in hand-held home videos for a more pleasant viewing experience.
# Motion streamliner
* Increase the frame rate and interpolate frames to remove the jitters from fast motion, making it appear much smoother.
# Video Enhancements
* Fine-tune your video with a variety of controls such as increased contrast and saturation for a more cinematic look. Corel WinDVD employs the best upscaling technology available to turn a variety of standard-definition formats into a stunning high-definition experience.


text:
Already have an account?
Millions of ways to be remarkable. Join today.
We will never post without your permission
Privacy Policy / Terms of Use
Already have an account?
We will never post without your permission
Rainbow Hospice and Palliative Care
As a Pet Therapy Volunteer you and your pet will be assigned to visit patients in your own community. You bring your special skills and special friends to offer love and joy to our Hospice patients and their families. You help make final wishes come true. You and your pet are celebrities! Crowds in long term care facilities actually gather when they hear you might be coming today. But the patient, most of all, looks forward to your visit as they may be bed-bound. Often, you are their hope.
Helping to care for our patients and families is a critical role played by our volunteers. Volunteers in Patient Care and Family Support provide in-home services to patients currently being served by Rainbow Hospice. Because of the direct patient and family interaction, all of these positions require Patient Care and Family Support volunteers to go through specialized Patient Care Training. This process teaches you about hospice and terminal illness and helps prepare volunteers to interact with and support our patients and families.
Day(s) Needed: Weekdays, Evenings or Weekends
Time(s) Needed: Preferably in 3-4 hour time blocks, flexible schedules based on volunteer availability.
Key Requirements:
We'll work with your schedule.
Volunteer near your homeLa Grange, IL 60525


text:
30 Mode CORDLESS alternative for Hitachi Magic Wand Massager manufactured for relieving tension and relaxing sore muscles. Stronger vibrations (Max RPM 7,000) and 20 Speed and 10 pattern settings, Range of attachments
Pocket size Ultrasonic Mesh Nebulizer for easy treatment of Asthma and Chronic Obstructive Pulmonary Disease (COPD) for infants and adults.
View Product
Regular Price:
Now Only
Starting at:
Regular Price:
Now Only
Regular Price:
Now Only
3 Item(s)
View as:
Regular Price:
Now Only
and be the first about our special
Here at Caremax we pride ourselves on fast, free and quality shipping. We offer free shipping for most items via Australian Post eParcel service - (additional shipping cost applies on Vibration machine and Tens Accessories.) We aim to ship your order on the same day (Cut-off 2pm) and specialise on getting your order out to you as quickly as possible. Delivery of goods usually takes between 3-10 working days, depending on which part of Australia you live.
Once you have placed your order you will be able to track you parcel from the moment it leaves our warehouse to the moment it arrives on your front door. You can do this all from the Caremax website under the Customer Care section!
In the event that you're not at home at the time of delivery you will be left a calling card inside your mailbox requesting you to contact our courier company to arrange an alternate time of delivery or you can pick up your order at your local Courier depot.
For security purposes all items must be signed for and cannot be left at your premises without a signature. If you would like the item to be left on your premises in the event you are not home, please put a note on your order where you would like the parcel to be left and we will ensure this happens for you.
If you have received anything that is not correct, faulty, damaged, or just want to follow up on your order please feeling free to email firstname.lastname@example.com and we will discuss how to rectify this as quickly and as smoothly as possible for you.
100% Australian Warranty:
At Caremax, our products are sourced from genuine manufacturers only. When you purchase from us, you can be assured that all of our products are fully covered by Australian warranties and adhere to all Australian safety standards.
Should you experience any problems with your purchase within the warranty period, you can rest assured it will be repaired locally by an authorised repairer with genuine manufacturer parts.
Lowest Price Guaranteed:
Here at Caremax we pride ourselves on supplying our customers with the best pricing possible!
We are often running promotions and specials week by week, so be sure to sign up to our mailing list to be kept in the loop!
We stand by our products and our staff are trained and passionate about the products we sell.
60 Days Money Back Guarantee & NO FUSS RETURN:
We offer 60 Days money back guarantee - NO EXCUSES.
Most items can be returned within 60 days of receiving the item. Within 60 days of receiving the items, if you are not 100% satisfied with the item, you may return it for full refund (excluding shipping charges). If your return is a result of our error we will also refund your shipping charge.
Do you want to return a faulty or incorrect item? No problem!
Caremax offer and fast and easy returns policy. We take great pride in our products, and hope you are delighted with your purchase or gift from Caremax. If for any reason you aren't completely satisfied, we make it easy to get exactly what you want.
All returns may be made via courier. Please include a copy of your proof of purchase in with your package.
If your goods are faulty or incorrect please email email@example.com will arrange for your item to be swiftly picked up and returned to Caremax to repair or replace and your item to be sent back to you as quickly and smoothly as possible!
If for some reason you have selected the wrong colour, size or simply change your mind on the item you have purchased please contact us as soon as possible. If your item hasn't been shipped yet we are happy to change your order, however, once your order is logged on the courier we are unable to make any changes – however please feel free to contact us and we will do our best to help you!
For Hygiene reasons we cannot return some items such as magic wand massager, attachment etc.
We appreciate your business and always try our best to make your Caremax shopping experience a happy one, however we do realize that from time to time things can go wrong.
We're here to help! Email us at firstname.lastname@example.com Monday-Sunday 7am-11pm AEST;
Le Reve HealthCare (ACN: 148 199 848) operated under Business Name CareMax, is a dedicated company in giving people the best designed and performance HealthCare Products on the market today. Located in Melbourne, Our Mission is to provide the very best products with the latest technology for the need of the Australian Customers.


text:
Nationally Accredited US Colleges and Universities
Search over 7,000 nationally and regionally accredited colleges across the country.
If you are looking for a list of accredited colleges, you have come to the right place. DegreeSearch.org is your one stop site for all things related to obtaining an online degree. Our free services help you find the right school to fit your schedule, financial situation and other needs, so that you can move up in the workplace and succeed in life. When you are searching for US colleges, accreditation is extremely important, as it is the one way you can ensure the university is recognized as a quality institution with proper credentials and coursework.
Find a college by State
- Alabama
- Alaska
- Arizona
- Arkansas
- California
- Colorado
- Connecticut
- Delaware
- District of Columbia
- Florida
- Georgia
- Hawaii
- Idaho
- Illinois
- Indiana
- Iowa
- Kansas
- Kentucky
- Louisiana
- Maine
- Maryland
- Massachusetts
- Michigan
- Minnesota
- Mississippi
- Missouri
- Montana
- Nebraska
- Nevada
- New Hampshire
- New Jersey
- New Mexico
- New York
- North Carolina
- North Dakota
- Ohio
- Oklahoma
- Oregon
- Pennsylvania
- Rhode Island
- South Carolina
- South Dakota
- Tennessee
- Texas
- Utah
- Vermont
- Virginia
- Washington
- West Virginia
- Wisconsin
- Wyoming
Degrees from nationally and regionally accredited colleges hold more credit in the eyes of employers, but there are several other benefits as well. Accredited colleges and universities allow you the same rights with registration, admission, counseling, financial aid, tutoring and other services. Nationally and state accredited colleges are the only schools that can participate in government student aid programs. As if that weren't enough, US accredited colleges make it easier to transfer credits, so if you plan to change schools or attend a physical location later, this saves you the headache of watching it all go to waste.
Looking for nationally accredited colleges and universities can be a headache in and of itself, but with DegreeSearch.org, we give you a full list of accredited colleges to make the process simpler. Whether state, regionally or nationally accredited, these listed colleges offer a variety of programs and degrees from which to choose, which gives you the best chance at success.
If you are looking online for degree programs that fit your lifestyle, degrees from accredited colleges give you the largest leg up in the employment market. Browse our collective listing of US accredited colleges and start your future today.


text:
Already Subscribed? Click here to login.
Subscribe to updates from the Ashland Oregon Chamber of Commerce, and you'll get emails announcing new topics and the outcome of existing topics.
Subscribe me to the selected tools below..
Note: You will receive an email verifying your subscription to this site. You must follow the instructions in the email to complete your subscription.
Your subscription has been successfully submitted!
Become a Member
Find a Business or Service
Calendar of Events
Maps & Vistors Info
Send A Postcard
Subscribe for Email Alerts
Friend us on Facebook
Contact Us
Request a Visitors Guide
Events Home
4th of July Parade & Celebration
Ashland Culinary Festival
Children's Halloween Parade
Festival of Light
Calendar of Events
Art & Craft Fairs in Ashland
Visitors Home
Change with a Purpose
The Ashland Map Guide
Relax & Refresh
Sample Itineraries
Traveling to Ashland
Ashland 4 Kids
Request a Publication
Meetings & Conventions
Industry Press Kit
Contact Us
Advertising and Media
Animals, Pets and Veterinary
Arts, Culture and Entertainment
Business and Professional Services
Community, Family and Non-Profit
Electronic Communications
Finance and Insurance
Government & Education
Health & Wellness
Home and Garden
Innovative Manufacturing
Lodging, Travel and Tourism
Personal Services and Care
Public Utilities and Environment
Real Estate and Construction
Religious Organizations
Restaurants, Food and Beverage
Senior Living
Shopping and Specialty Retail
Sports and Recreation
Local Home
Gift Certificate
Ashland Forest Resiliency Stewardship Project
Living Local
Relocation Information
Demographics & Housing
Request a Relocation Guide
Art & Craft Fair in Ashland
Contact Us
Your Chamber
Your Chamber Home
Ashland Business Resource Website
Member Directory
Annual Dinner Recap
Legislative Forum
Chamber Community Events
Gift Certificate Program
Board & Staff
Greeter's Meetings
Volunteer Application
Programs & Committees
Rapid Response Team
Chamber History
Ashland Economy
Contact Us


text:
Day two had more Madness and it finally resembled tourneys of the past with upsets and game going down to the wire. We had major programs get beat by the deadly "Mid-Major" and say some great individual performances.
1. Domination of the Day: Louisville over Morehead State. Runner-up: Cleveland State over Wake Forrest.
2. Performance of the Day: Ben Woodside of North Dakota State scored 37 points in the Bison lose to Kansas. Woodside shot 13-for-23 from the field and 8-for-10 from the foul-line. Runner-up: Sherron Collins of Kansas.
3. Upset of the Day: There are a couple to pick from, but Cleveland State over Wake Forrest is the obvious choice. Plus they were dominate in this game. The Vikings looked like the higher seed.
Telling stat of the game: Cleveland State had six turn overs, WF had 18.
4. Game of the Day: Again, there were many to pick from, but I think the best game was the Oklahoma State over Tennessee.
5. Bison Review: I would say that I was happy with the way the Bison played and Kansas took advantage of NDSU's weakness in the post. NDSU was able to hit from deep, but had no counter punch to Cole Aldirch down low. I was glad to see Woodside play well and he kept the Bison in the game. He was able to get to the basket very easily and showed that he is a talented player. The battle between him and Collins was great.
6. Overall Feeling on the Day: Other than the 16 vs. 1 seeds – and a couple other random games – the quality of play has been very high in this tournament, and the second day of Big Dance Madness was nothing less.


text:
As you can see, Judy was always very creative, especially when she had an ulterior motive. I can remember receiving this wonderful newsletter when I was so homesick for family and Penrose, and laughing at the inventiveness of my "little" sister. Be sure to enlarge this so that you can read it. Only family members can interpret certain parts of this letter.
Happy birthday, Judy!